Now showing items 1-10 of 3

    Adult (3)
    Antineoplastic Combined Chemotherapy Protocols (3)
    Female (3)
    Humans (3)
    Male (3)
    Middle Aged (3)
    Protein Kinase Inhibitors (3)
    Aged (2)
    Clinical Trials, Phase I as Topic (2)
    Phosphoinositide-3 Kinase Inhibitors (2)